Dare Bioscience, Inc. — Director's Dealing 2015

Jun 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-06-26

Reporting Person: Arbuckle Stuart A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-26	Stock Option (Right to Buy)	$4.78	A	22000	Acquired	2025-06-25	Common Stock (22000)	Direct

Footnotes

F1: This option was granted on June 26, 2015. The shares underlying this option vest in three equal annual installments on June 26, 2016, June 26, 2017 and June 26, 2018, respectively, subject to Mr. Arbuckle's continued service as a director of the Corporation.